sumatriptan has been researched along with cilostazol in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 8 (88.89) | 24.3611 |
2020's | 1 (11.11) | 2.80 |
Authors | Studies |
---|---|
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Carøe Nordgaard, J; Gammeltoft, S; Kruse, LS; Kruuse, CR | 1 |
Ashina, M; Guo, S; Hansen, EK; Olesen, J | 1 |
Ashina, M; Dunga, BÓÁ; Falkenberg, K; Guo, S; Olesen, J | 1 |
Falkenberg, K; Olesen, J | 1 |
Amin, FM; Ashina, M; Christensen, CE; de Koning, PJH; Ghanizada, H; Khan, S; Larsson, HBW; Olinger, ACR; Younis, S | 1 |
Amin, FM; Ashina, M; Birgens, H; Christensen, CE; Daldrup-Link, H; Fliedner, FP; Khan, S; Kjær, A; Larsson, HBW; Lindberg, U; Olinger, ACR; Tolnai, D; Younis, S | 1 |
Bjerg, HR; Falkenberg, K; Olesen, J | 1 |
1 review(s) available for sumatriptan and cilostazol
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
6 trial(s) available for sumatriptan and cilostazol
Article | Year |
---|---|
Toward a pragmatic migraine model for drug testing: I. Cilostazol in healthy volunteers.
Topics: Adolescent; Adult; Cilostazol; Cross-Over Studies; Double-Blind Method; Female; Healthy Volunteers; Human Experimentation; Humans; Male; Middle Aged; Migraine Disorders; Sumatriptan; Tetrazoles; Vasoconstrictor Agents; Vasodilator Agents; Young Adult | 2016 |
Cilostazol induced migraine does not respond to sumatriptan in a double blind trial.
Topics: Adult; Cilostazol; Cross-Over Studies; Cyclic AMP; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Models, Neurological; Phosphodiesterase 3 Inhibitors; Serotonin 5-HT1 Receptor Agonists; Sumatriptan; Surveys and Questionnaires; Tetrazoles; Treatment Failure; Young Adult | 2018 |
Pre-treatment with sumatriptan for cilostazol induced headache in healthy volunteers.
Topics: Adult; Cilostazol; Cross-Over Studies; Double-Blind Method; Female; Headache; Healthy Volunteers; Humans; Male; Middle Aged; Migraine Disorders; Sumatriptan; Surveys and Questionnaires; Tetrazoles; Vasoconstrictor Agents; Vasodilator Agents; Young Adult | 2018 |
Meningeal contribution to migraine pain: a magnetic resonance angiography study.
Topics: Adolescent; Adult; Carotid Arteries; Cilostazol; Female; Headache; Humans; Magnetic Resonance Angiography; Meningeal Arteries; Middle Aged; Migraine Disorders; Pain Measurement; Sumatriptan; Vasodilation; Young Adult | 2019 |
Investigating macrophage-mediated inflammation in migraine using ultrasmall superparamagnetic iron oxide-enhanced 3T magnetic resonance imaging.
Topics: Adult; Animals; Brain; Cilostazol; Dextrans; Female; Humans; Inflammation; Macrophages; Magnetic Resonance Imaging; Magnetite Nanoparticles; Mice; Middle Aged; Migraine Disorders; Neuroimaging; Serotonin 5-HT1 Receptor Agonists; Sumatriptan; Vasodilator Agents | 2019 |
Subcutaneous sumatriptan reduces cilostazol induced headache in migraine patients.
Topics: Adult; Cilostazol; Cross-Over Studies; Double-Blind Method; Female; Humans; Injections, Subcutaneous; Male; Middle Aged; Migraine Disorders; Serotonin 5-HT1 Receptor Agonists; Sumatriptan; Vasodilator Agents; Young Adult | 2020 |
2 other study(ies) available for sumatriptan and cilostazol
Article | Year |
---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Role of Ser102 and Ser104 as regulators of cGMP hydrolysis by PDE5A.
Topics: Amino Acid Substitution; Calcitonin Gene-Related Peptide; Catalytic Domain; Cell Line; Cilostazol; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Humans; In Vitro Techniques; Models, Molecular; Nitroglycerin; Phosphodiesterase Inhibitors; Piperazines; Purines; Serine; Sildenafil Citrate; Sulfonamides; Sumatriptan; Tetrazoles | 2014 |